These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 19467809)

  • 1. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential nanomedicine consisting of heparin-loaded polysaccharide nanocarriers for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Alonso MJ; Torres D
    Macromol Biosci; 2012 Feb; 12(2):176-83. PubMed ID: 22109995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
    Krauland AH; Alonso MJ
    Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
    Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
    Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
    de la Fuente M; Seijo B; Alonso MJ
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
    Lu HD; Zhao HQ; Wang K; Lv LL
    Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, optimization, and in-vitro/in-vivo/ex-vivo characterization of chitosan-heparin nanoparticles: drug-induced gelation.
    Shahbazi MA; Hamidi M; Mohammadi-Samani S
    J Pharm Pharmacol; 2013 Aug; 65(8):1118-33. PubMed ID: 23837580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy.
    Colonna C; Conti B; Perugini P; Pavanetto F; Modena T; Dorati R; Iadarola P; Genta I
    Eur J Pharm Biopharm; 2008 Sep; 70(1):58-65. PubMed ID: 18547793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles.
    Trapani A; Di Gioia S; Ditaranto N; Cioffi N; Goycoolea FM; Carbone A; Garcia-Fuentes M; Conese M; Alonso MJ
    Int J Pharm; 2013 Apr; 447(1-2):115-23. PubMed ID: 23454518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
    Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
    J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
    Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
    Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
    Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
    J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
    Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
    Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.